Skip to content

Treatment Group:Local and Intratumoral Administration

5 trials

Sponsors

The First Affiliated Hospital Of Guangzhou Medical College, Beijing Cancer Hospital, Cancer Institute & Hospital, Chinese Academy of Medical Sciences

Conditions

Advanced Liver CancerAdvanced Lung CancerNewly Diagnosed Breast CancerPalpable solid tumorStage I to II Squamous Cell Carcinoma

Phase 2

A Phase IIb Clincal Trial Treating Patients with Advanced Liver Cancer with PTS (Para-Toluenesulfonamide Injection), A Novel Local Invasive Anticancer Drug, by Percutaneous Intratumoral Injection Therapy
Active, not recruitingChiCTR-ONC-12002943
Beijing Cancer HospitalAdvanced Liver Cancer
Start: 2005-07-19Updated: 2017-04-18
A Phase IIa Clinical Trial Treating Patients With Early Stage Head and Neck Tumor (SCCHN & SCSC) for Not Exceeding 7 Days Prior Surgery With PTS (para-toluenesulfonamide injection), A Novel Local Invasive Anticancer Drug, Administered By Local and Intratumoral Injection Therapy
Active, not recruitingChiCTR-ONC-12002948
Cancer Institute & Hospital, Chinese Academy of Medical SciencesStage I to II Squamous Cell Carcinoma
Start: 2002-05-13Updated: 2017-04-18
A Phase IIb Clincal Trial Treating Patients with Advanced Palpable Solid Tumor After Failure From Conventional Treatments and Patients Who are Suitable for Palliative Treatments with PTS(para-toluenesulfonamide injection), A Novel Local Invasive Anticancer Drug, by Intratumoral Injection Therapy
Active, not recruitingChiCTR-ONC-12002944
Beijing Cancer HospitalPalpable solid tumor
Start: 2005-07-19Updated: 2017-04-18
A Phase IIa Clincal Trial Treating Patients With Early Stage Breast Cancer for Not Exceding 7 Days Prior Surgery With PTS(para-toluenesulfonamide injection), A Novel Local Invasive Anticancer Drug, Administered By Local and Intratumoral Injection Therapy
Active, not recruitingChiCTR-ONC-12002946
Beijing Cancer HospitalNewly Diagnosed Breast Cancer
Start: 2002-02-09Updated: 2017-04-18
A Phase IIb Clinical Study of PTS (Para-Toluenesulfonamide Injection), A Novel Local Invasive Anticancer Drug, Administered Locally and Intratumorally to Patients With Advanced Lung Cancer
Active, not recruitingChiCTR-ONC-12002942
The First Affiliated Hospital Of Guangzhou Medical CollegeAdvanced Lung Cancer
Start: 2005-07-19Updated: 2017-04-18